{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2021/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Lin Yan", "item": "https://www.patentleaderboard.com/2021/inventor/fl:li_ln:yan-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
LY

Lin Yan — 2 Patents in 2021

Merck: 2 patents #121 of 909Top 15%
East Brunswick Township, NJ: #13 of 76 inventorsTop 20%
New Jersey: #1,156 of 6,977 inventorsTop 20%
Overall (2021): #137,305 of 548,734Top 30%
2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11058775 Insulin dimer-incretin conjugates Anandan Palani, Zhiqiang Yang, Songnian Lin, Pei Huo, Ravi Nargund 2021-07-13 $96,899,000
11041009 Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes Danqing Feng, Pei Huo, Ahmet Kekec, Songnian Lin, Christopher Moyes +4 more 2021-06-22 $110,392,000